New Zealand - Inggeris - Medsafe (Medicines Safety Authority)

stallergenes greer new zealand ltd - allergen extracts 0.1 ir/ml (dermatophagoides pteronyssinus body extract); allergen extracts 1 ir/ml (dermatophagoides pteronyssinus body extract); allergen extracts 10 ir/ml (dermatophagoides pteronyssinus body extract) - solution for injection - active: allergen extracts 0.1 ir/ml (dermatophagoides pteronyssinus body extract) excipient: aluminium hydroxide gel mannitol phenol sodium chloride water active: allergen extracts 1 ir/ml (dermatophagoides pteronyssinus body extract) excipient: aluminium hydroxide gel mannitol phenol sodium chloride water active: allergen extracts 10 ir/ml (dermatophagoides pteronyssinus body extract) excipient: aluminium hydroxide gel mannitol phenol sodium chloride water

New Zealand - Inggeris - Medsafe (Medicines Safety Authority)

stallergenes greer new zealand ltd - allergen extracts 0.1 ir/ml (d. glomerate (20%), f. elatior (20%), l. perenne (20%), a. odoratum (20%), p. pratense (20%) extract); allergen extracts 1 ir/ml (d. glomerate (20%), f. elatior (20%), l. perenne (20%), a. odoratum (20%), p. pratense (20%) extract); allergen extracts 10 ir/ml (d. glomerate (20%), f. elatior (20%), l. perenne (20%), a. odoratum (20%), p. pratense (20%) extract) - solution for injection - active: allergen extracts 0.1 ir/ml (d. glomerate (20%), f. elatior (20%), l. perenne (20%), a. odoratum (20%), p. pratense (20%) extract) excipient: aluminium hydroxide gel mannitol phenol sodium chloride water active: allergen extracts 1 ir/ml (d. glomerate (20%), f. elatior (20%), l. perenne (20%), a. odoratum (20%), p. pratense (20%) extract) excipient: aluminium hydroxide gel mannitol phenol sodium chloride water active: allergen extracts 10 ir/ml (d. glomerate (20%), f. elatior (20%), l. perenne (20%), a. odoratum (20%), p. pratense (20%) extract) excipient: aluminium hydroxide gel mannitol phenol sodium chloride water - alustal treatment is indicated for patients with type 1 allergy (gell and coombs classification), particularly presenting as seasonal or perennial rhinitis, conjunctivitis, rhinoconjunctivitis with or without associated asthma.

New Zealand - Inggeris - Medsafe (Medicines Safety Authority)

stallergenes greer new zealand ltd - allergen extracts 0.1 ic/ml (fraxinus excelsior (33.33%), olea europaea (33.33%), ligustrum vulgare (33.33%) pollen extracts); allergen extracts 1 ic/ml (fraxinus excelsior (33.33%), olea europaea (33.33%), ligustrum vulgare (33.33%) pollen extracts); allergen extracts 10 ic/ml (fraxinus excelsior (33.33%), olea europaea (33.33%), ligustrum vulgare (33.33%) pollen extracts) - solution for injection - active: allergen extracts 0.1 ic/ml (fraxinus excelsior (33.33%), olea europaea (33.33%), ligustrum vulgare (33.33%) pollen extracts) excipient: aluminium hydroxide gel mannitol phenol sodium chloride water active: allergen extracts 1 ic/ml (fraxinus excelsior (33.33%), olea europaea (33.33%), ligustrum vulgare (33.33%) pollen extracts) excipient: aluminium hydroxide gel mannitol phenol sodium chloride water active: allergen extracts 10 ic/ml (fraxinus excelsior (33.33%), olea europaea (33.33%), ligustrum vulgare (33.33%) pollen extracts) excipient: aluminium hydroxide gel mannitol phenol sodium chloride water

New Zealand - Inggeris - Medsafe (Medicines Safety Authority)

ebos group ltd - allergen extracts 10 ic/ml (alternaria alternata (50%), alternaria longipes (50%) extracts) - solution for injection - 10 ic/ml - active: allergen extracts 10 ic/ml (alternaria alternata (50%), alternaria longipes (50%) extracts) excipient: aluminium hydroxide gel mannitol phenol sodium chloride water

New Zealand - Inggeris - Medsafe (Medicines Safety Authority)

ebos group ltd - allergen extracts 10 ic/ml (a. absinthium (25%), t. vulgarae (25%), x. strumarium (25%), c. leucanthemum (25%) pollen extract) - solution for injection - 10 ic/ml - active: allergen extracts 10 ic/ml (a. absinthium (25%), t. vulgarae (25%), x. strumarium (25%), c. leucanthemum (25%) pollen extract) excipient: aluminium hydroxide gel mannitol phenol sodium chloride water

New Zealand - Inggeris - Medsafe (Medicines Safety Authority)

ebos group ltd - allergen extracts 0.1 ic/ml (chicken (33%), duck (33%), goose (33%) feathers extract); allergen extracts 1 ic/ml (chicken (33%), duck (33%), goose (33%) feathers extract); allergen extracts 10 ic/ml (chicken (33%), duck (33%), goose (33%) feathers extract) - solution for injection - active: allergen extracts 0.1 ic/ml (chicken (33%), duck (33%), goose (33%) feathers extract) excipient: aluminium hydroxide gel mannitol phenol sodium chloride water active: allergen extracts 1 ic/ml (chicken (33%), duck (33%), goose (33%) feathers extract) excipient: aluminium hydroxide gel mannitol phenol sodium chloride water active: allergen extracts 10 ic/ml (chicken (33%), duck (33%), goose (33%) feathers extract) excipient: aluminium hydroxide gel mannitol phenol sodium chloride water

Australia - Inggeris - Department of Health (Therapeutic Goods Administration)

stallergenes australia pty ltd - plantago lanceolata -

Amerika Syarikat - Inggeris - NLM (National Library of Medicine)

alk-abello, inc. - phleum pratense pollen (unii: 65m88rw2eg) (phleum pratense pollen - unii:65m88rw2eg), dactylis glomerata pollen (unii: 83n78ida7p) (dactylis glomerata pollen - unii:83n78ida7p), poa pratensis pollen (unii: scb8j7ls3t) (poa pratensis pollen - unii:scb8j7ls3t), agrostis gigantea pollen (unii: hu8v6e7hoa) (agrostis gigantea pollen - unii:hu8v6e7hoa), anthoxanthum odoratum pollen (unii: 2kik19r45y) (anthoxanthum odoratum pollen - unii:2kik19r45y) - phleum pratense pollen 20000 [bau] in 1 ml - indicated use of allergenic extracts is for the diagnosis and treatment (hyposensitization therapy) of patients who experience allergic symptoms due to exposure to grass pollen and who exhibit type i skin sensitivity when tested to those specific allergens. hyposensitization (injection) therapy is a treatment for patients exhibiting allergic reactions to seasonal pollens, dust mites, molds, animal danders, and various other inhalants in situations where the offending allergen cannot be avoided. for previously untreated patients, prior to the initiation of therapy, clinical sensitivity to the standardized grass pollen extract should be established by careful evaluation of the patient's history confirmed by diagnostic skin testing. hyposensitization should not be prescribed for sensitivities to allergens which can easily be avoided. 10,000 bau/ml extracts are indicated for percutaneous testing. if negative, the 100,000 bau/ml dose may be used. availability of 10,000 and 100,000 bau/ml dosages facilitate safe

Amerika Syarikat - Inggeris - NLM (National Library of Medicine)

allergy laboratories, inc. - cynodon dactylon pollen (unii: 175f461w10) (cynodon dactylon pollen - unii:175f461w10) - cynodon dactylon pollen 10000 [bau] in 1 ml -       standardized grass pollen extracts are used for the diagnosis and treatment of allergic disease to grass pollen. the standardized (bioequivalent allergy unit) extract in these vials is designed primarily for the physician equipped to prepare dilutions and mixtures as required. standardized grass pollen extracts l a beled in bau/ml are not interchangeable with grass pollen extracts labeled in au/ml or with non-standardized (weight/volume) grass pollen extracts. patients being switched from other types of extracts to allergy laboratories should have their dose adjusted. diagnosis of allergic disease to these grasses is made through a combined medical history sufficiently complete to identify allergic symptoms to grass pollen and identification of grass allergy by diagnostic skin testing. it is recommended that diagnostic skin testing (scratch or puncture) be performed with 10,000 bau/ml grass pollen extracts before testing with 100,000 bau/ml grass pollen extracts. 10,000 bau/ml and 100,000 bau/ml gras

New Zealand - Inggeris - Medsafe (Medicines Safety Authority)

stallergenes greer new zealand ltd - grass pollen extract 100 ir; allergen extracts 300 ir (grass pollen) - sublingual tablet - active: grass pollen extract 100 ir excipient: colloidal silicon dioxide croscarmellose sodium lactose magnesium stearate microcrystalline cellulose active: allergen extracts 300 ir (grass pollen) excipient: colloidal silicon dioxide croscarmellose sodium lactose magnesium stearate microcrystalline cellulose - treatment of grass pollen allergic rhinitis with or without conjunctivitis in adults, adolescents and children (above the age of 5) with clinically relevant symptoms, confirmed by a positive cutaneous test and/or a positive titre of the specific ige to the grass pollen.